The monoclonal antibodies market is projected to grow at a CAGR of 5.77% to reach US$158.598 billion by 2025, from US$106.134 billion in 2019. The monoclonal antibodies market consists of sales of monoclonal antibodies and related services. Monoclonal antibodies are used to enhance and suppress the immune response in various medical conditions and to treat various diseases such as cancer, cardiovascular and cerebrovascular diseases.